A further 6 DFSP patients treated with Glivec were reported in 5 published case reports, their ages ranging from 18 months to 49 years.
Hiljem on viies avaldatud haigusjuhu kirjelduses teatatud veel kuuest DFSP patsiendist vanuses 18 kuud kuni 49 aastat.